Tuesday, November 1, 2022

CDC pressured government agencies to approve COVID-19 boosters without reviewing clinical trial data

 Newly uncovered documents reveal that the Centers for Disease Control and Prevention pressured other federal regulators, including the Food and Drug Administration, to clear the Wuhan coronavirus vaccine boosters without clinical trial data.

The emails began in early Aug. 2021 between CDC officials and their counterparts in the FDA. The CDC wanted the FDA to authorize the Moderna and Pfizer COVID-19 boosters despite clinical trial data showing that the vaccines were not working as well as initially proclaimed.

One conversation, described by now former FDA Deputy Chief for Vaccines Dr. Phil Krause, involved the CDC "Hoping" that the FDA will approve emergency use authorization for a third dose of the vaccine for immunocompromised individuals.

TV CDC pressured FDA to change views regarding booster vaccines When the FDA authorized the boosters, then-Acting Commissioner Dr. Janet Woodcock claimed at the time that individuals who are fully vaccinated are already "Adequately protected" and do not need any additional doses.

This view would change just weeks later, thanks to CDC intervention when Woodcock and CDC Director Dr. Rochelle Walensky signed a joint statement claiming that vaccine protection was waning and that everyone needed boosters "To maximize vaccine-induced protection and prolong its durability." Both the FDA and the CDC would later authorize Pfizer's COVID-19 booster vaccine for most other Americans, followed by Moderna's and Johnson & Johnson's boosters.

Krause would later resign from his position in the CDC over his opposition to the booster vaccine strategy.

Dr. Marion Gruber, who resigned from the FDA at the same time as Krause, noted in earlier emails that he was also concerned about pressure to authorize the vaccines coming from Big Pharma companies like Pfizer.

https://www.naturalnews.com/2022-10-31-cdc-pressured-government-approve-covid-boosters.html

No comments: